6.
Bachhuber M, Thompson C, Prybylowski A, Benitez MSW J, Mazzella MA S, Barclay D
. Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program. Subst Abus. 2018; 39(2):167-172.
PMC: 9333078.
DOI: 10.1080/08897077.2018.1443541.
View
7.
Chan P, Nunn A, Berg J, Cormier K, Sowemimo-Coker G, Napoleon S
. A Randomized Trial of a Brief Behavioral Intervention for PrEP Uptake Among Men Who Have Sex With Men at Increased Risk for HIV Infection. J Acquir Immune Defic Syndr. 2021; 87(3):937-943.
PMC: 8192434.
DOI: 10.1097/QAI.0000000000002671.
View
8.
Whitfield T, John S, Rendina H, Grov C, Parsons J
. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men. AIDS Behav. 2018; 22(11):3566-3575.
PMC: 6077114.
DOI: 10.1007/s10461-018-2045-1.
View
9.
Molina J, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G
. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Lancet HIV. 2022; 9(8):e554-e562.
DOI: 10.1016/S2352-3018(22)00133-3.
View
10.
Hughes S, Koester K, Engesaeth E, Hawkins M, Grant R
. Human Enough: A Qualitative Study of Client Experience With Internet-Based Access to Pre-exposure Prophylaxis. J Med Internet Res. 2022; 23(7):e22650.
PMC: 8406118.
DOI: 10.2196/22650.
View
11.
Wahnich A, Gandhi A, Cleghorn E, Estacio K, Blackstock O, Myers J
. Public Health Detailing to Promote HIV Pre- and Postexposure Prophylaxis Among Women's Healthcare Providers in New York City. Am J Prev Med. 2021; 61(5 Suppl 1):S98-S107.
DOI: 10.1016/j.amepre.2021.05.032.
View
12.
Myers J, Braunstein S, Xia Q, Scanlin K, Edelstein Z, Harriman G
. Redefining Prevention and Care: A Status-Neutral Approach to HIV. Open Forum Infect Dis. 2018; 5(6):ofy097.
PMC: 6016418.
DOI: 10.1093/ofid/ofy097.
View
13.
Strand M, Bratberg J, Eukel H, Hardy M, Williams C
. Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic. Prev Chronic Dis. 2020; 17:E69.
PMC: 7380294.
DOI: 10.5888/pcd17.200317.
View
14.
Peng P, Su S, Fairley C, Chu M, Jiang S, Zhuang X
. A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis. AIDS Behav. 2017; 22(4):1063-1074.
DOI: 10.1007/s10461-017-1675-z.
View
15.
Stekler J, McMahan V, Ballinger L, Viquez L, Swanson F, Stockton J
. HIV Pre-exposure Prophylaxis Prescribing Through Telehealth. J Acquir Immune Defic Syndr. 2017; 77(5):e40-e42.
DOI: 10.1097/QAI.0000000000001621.
View
16.
Chasco E, Hoth A, Cho H, Shafer C, Siegler A, Ohl M
. Mixed-Methods Evaluation of the Incorporation of Home Specimen Self-Collection Kits for Laboratory Testing in a Telehealth Program for HIV Pre-exposure Prophylaxis. AIDS Behav. 2021; 25(8):2463-2482.
PMC: 7975241.
DOI: 10.1007/s10461-021-03209-9.
View
17.
Storholm E, Siconolfi D, Huang W, Towner W, Ling Grant D, Martos A
. Project SLIP: Implementation of a PrEP Screening and Linkage Intervention in Primary Care. AIDS Behav. 2021; 25(8):2348-2357.
PMC: 8556139.
DOI: 10.1007/s10461-021-03197-w.
View
18.
Qato D, Zenk S, Wilder J, Harrington R, Gaskin D, Alexander G
. The availability of pharmacies in the United States: 2007-2015. PLoS One. 2017; 12(8):e0183172.
PMC: 5559230.
DOI: 10.1371/journal.pone.0183172.
View
19.
Siegler A, Mayer K, Liu A, Patel R, Ahlschlager L, Kraft C
. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program. Clin Infect Dis. 2018; 68(3):501-504.
PMC: 6336909.
DOI: 10.1093/cid/ciy529.
View
20.
Hubach R, Currin J, Sanders C, Durham A, Kavanaugh K, Wheeler D
. Barriers to Access and Adoption of Pre-Exposure Prophylaxis for the Prevention of HIV Among Men Who Have Sex With Men (MSM) in a Relatively Rural State. AIDS Educ Prev. 2017; 29(4):315-329.
DOI: 10.1521/aeap.2017.29.4.315.
View